Topics

Neuroendocrine Tumor Research Foundation Company Profile

10:04 EST 27th January 2020 | BioPortfolio


News Articles [1489 Associated News Articles listed on BioPortfolio]

NETRF-funded research may help predict pancreatic neuroendocrine tumor (pNET) recurrence

(Neuroendocrine Tumor Research Foundation) NETRF-funded researchers identified a cancer cell type that is associated with non-functional pancreatic neuroendocrine tumor (pNET) recurrence. Alpha-like p...

Children's Tumor Foundation and DELopen increase access to compounds for neurofibromatosis

(Children's Tumor Foundation ) The Children's Tumor Foundation (CTF), an innovative and global neurofibromatosis research foundation announced today a collaboration with DELopen, a DNA-encoded library...

Wireless Zone® Donated $25,000 to the Children’s Tumor Foundation in October

MIDDLETOWN, Conn. (PRWEB) January 01, 2020 Wireless Zone®, a Verizon authorized retailer and the nation’s largest wireless...

Natera, Foundation Medicine partner on tumor DNA monitoring assays

Foundation Medicine and Natera have entered an agreement to develop and market personalized circulating tumor DNA monitoring  -More- 

CTF, DELopen jointly offer unique opportunities to neurofibromatosis research community

The Children's Tumor Foundation, an innovative and global neurofibromatosis (NF) research foundation announced today a collaboration with DELopen, a DNA-encoded library technology platform sponsored b...

2019 Neuroendocrine Carcinoma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Neuroendocrine Carcinoma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Neuroendocrine Carcinoma. It presents indepth ...

Wireless Zone® Donated $25,000 to the Children’s Tumor Foundation in October

Money was collected by local retailers through the Wireless Zone Foundation for Giving®, which donates thousands of dollars annually to its core charities including the Children’s Tumor Foundat...

2019 Neuroendocrine Carcinoma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Report Updated: 24042019] Prices from USD $1529

The global clinical trial report 2019 Neuroendocrine Carcinoma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Neuroendocrine Carcinoma. It presents indepth ...

Drugs and Medications [104 Associated Drugs and Medications listed on BioPortfolio]

Fludeoxyglucose f18 [the methodist hospital research institute]

Fludeoxyglucose F18 Injection USP - NO CHANGE

Trichloroacetic acid 15% [crc (cosmoceutical research center)]

NA

Trichloroacetic acid 50% [crc (cosmoceutical research center)]

NA

Trichloroacetic acid 30% [crc (cosmoceutical research center)]

NA

Sutent [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use SUTENT safely and effectively. See full prescribing information for SUTENT. SUTENT (sunitinib malate) capsules, for oral useInitial U....

PubMed Articles [3888 Associated PubMed Articles listed on BioPortfolio]

The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.

This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the surgical management of pancreatic neuroendocrine tumors from July 19 to 20, 2018. The group...

Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis.

The European Neuroendocrine Tumor Society (ENETS) guidelines advocate a right hemicolectomy (RHC) only in patients with appendiceal neuroendocrine neoplasms (aNENs) at risk for N+(node positive). The ...

The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.

There are few effective biomarkers for neuroendocrine tumors. Precision oncology strategies have provided liquid biopsies for real-time and tailored decision-making. This has led to the development of...

A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification.

According to the 2017 World Health Organization classification, pancreatic neuroendocrine neoplasms (PanNENs) include a new category of pancreatic neuroendocrine tumor, grade 3, which is often difficu...

Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms (H-NENs): histology and molecular analysis, two sides of the same coin.

In gastroenteropancreatic (GEP) high-grade neuroendocrine neoplasms (H-NENs), Ki-67 threshold of 55%, instead of 20%, defines three prognosis subclasses: neuroendocrine tumor (NET) G3, neuroendocrine ...

Clinical Trials [8151 Associated Clinical Trials listed on BioPortfolio]

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Somatostatin receptor(SSTR) was expressed in neuroendocrine tumor cells and SSTR-targeting molecular imaging(68Ga-DOTATATE PET/CT) could be a promising technique to evaluate the primary tu...

Community-based Neuroendocrine Tumor (NET) Research Study

The purpose of this trial is to assess time to disease progression of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors treated with Lanreotide Depo...

Microbiotic Analysis in Digestive Endocrine Tumors

Incidence of digestive neuroendocrine tumors are increasing. Analysis of individual microbiota is a way to explore new neoplastic mechanisms, tumor identification and therapeutic orientati...

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

The aim of this study is to investigate the efficacy, safety, and survival benefit of etoposide plus cisplatin and irinotecan plus cisplatin in first-line therapy of non-primary pancreatic...

Clinical and Pathologic Studies in Neuroendocrine Tumors

This research involves the study of neuroendocrine tumors in order to better understand how the disease grows and spreads. This study requires will use tissue collected from from biopsies ...

Companies [2930 Associated Companies listed on BioPortfolio]

Neuroendocrine Tumor Research Foundation

The Ben and Catherine Ivy Foundation

The Ivy Foundation is the nation’s largest privately funded foundation dedicated to improving survival and quality of life for people diagnosed with a brain tumor.

National Brain Tumor Society (NBTS)

National Brain Tumor Society is the largest nonprofit organization dedicated to the brain tumor community in the United States. We are fiercely committed to finding better treatme...

AdnaGen AG

AdnaGen's diagnostics detect circulating tumor cells in tumor patients. Because tumor cells survive only hours in the bloodstream, there must be an active source, e.g. a relapse or a metastasis. There...

Brain Tumor Foundation

More Information about "Neuroendocrine Tumor Research Foundation" on BioPortfolio

We have published hundreds of Neuroendocrine Tumor Research Foundation news stories on BioPortfolio along with dozens of Neuroendocrine Tumor Research Foundation Clinical Trials and PubMed Articles about Neuroendocrine Tumor Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuroendocrine Tumor Research Foundation Companies in our database. You can also find out about relevant Neuroendocrine Tumor Research Foundation Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record